Mark William Lowdell is Chief Scientific Officer of Inmune Bio, Inc.. Currently has a direct ownership of 1.51 Million shares of INMB, which is worth approximately $6.9 Million. The most recent transaction as insider was on Apr 19, 2024, when has been sold 14,423 shares (Common Stock) at a price of $8.32 per share, resulting in proceeds of $119,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.51M
0% 3M change
0.96% 12M change
Total Value Held $6.9 Million

Mark William Lowdell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 19 2024
BUY
Grant, award, or other acquisition
$119,999 $8.32 p/Share
14,423 Added 0.95%
1,510,806 Common Stock
Mar 22 2022
BUY
Grant, award, or other acquisition
$198,864 $8.43 p/Share
23,590 Added 1.55%
1,496,383 Common Stock
Nov 03 2021
SELL
Open market or private sale
$14,020 $20.0 p/Share
701 Reduced 0.05%
1,472,793 Common Stock
Oct 27 2021
SELL
Open market or private sale
$47,140 $20.0 p/Share
2,357 Reduced 0.16%
1,473,494 Common Stock
Oct 22 2021
SELL
Open market or private sale
$8,000 $20.0 p/Share
400 Reduced 0.03%
1,475,851 Common Stock
Jul 08 2021
SELL
Open market or private sale
$487,589 $20.19 p/Share
24,150 Reduced 1.61%
1,476,251 Common Stock
Jul 07 2021
SELL
Open market or private sale
$117,117 $20.02 p/Share
5,850 Reduced 0.39%
1,500,401 Common Stock
MWL

Mark William Lowdell

Chief Scientific Officer
Boca Raton,, FL

Track Institutional and Insider Activities on INMB

Follow Inmune Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INMB shares.

Notify only if

Insider Trading

Get notified when an Inmune Bio, Inc. insider buys or sells INMB shares.

Notify only if

News

Receive news related to Inmune Bio, Inc.

Track Activities on INMB